Planta Med 2006; 72(6): 533-538
DOI: 10.1055/s-2006-931559
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Alkyl Phloroglucinol Derivatives from Syzygium levinei and their Differentiation-Inducing Activity

Jian Zou1 , 2 , [*] , Yi Mi2 , 3 , [*] , Wenliang Chen1 , 2 , Qunfang Liu1 , Jian Wang1 , Liguang Lou3 , Weimin Zhao1
  • 1Department of Natural Products Chemistry, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, P. R. China
  • 2Graduate School of the Chinese Academy of Sciences, Shanghai, P. R. China.
  • 3Department of Pharmacology, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, P. R. China
Further Information

Publication History

Received: July 26, 2005

Accepted: December 8, 2005

Publication Date:
28 April 2006 (online)

Zoom Image

Abstract

Eleven compounds have been identified from the whole plants of Syzygium levinei (Myrtaceae) on the basis of spectroscopic analysis and chemical methods. Among these compounds, (Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-oct-5-en-1-one (1), (3E,7Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-deca-3,7-dien-1-one (2), and 1-(2-O-β-D-glucopyranosyl-5,6-dihydroxy-4-methoxyphenyl)-octan-1-one (3) were characterized as new alkyl phloroglucinol derivatives, and 1-(2,6-dihydroxy-4-methoxyphenyl)-hexan-1-one (4) was identified as a new natural product. Compounds 1, 2, and 4 were found to inhibit the proliferation of leukemia K562 and HL-60 cells and also to induce the differentiation of K562 cells as determined by the appearance of matured morphology and the increase in the intracellular hemoglobin level.